Bactine® Max Liquid Bandage

Bactine Max by

Drug Labeling and Warnings

Bactine Max by is a Otc medication manufactured, distributed, or labeled by WellSpring Pharmaceutical Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

BACTINE MAX- benzalkonium chloride and lidocaine hydrochloride liquid 
WellSpring Pharmaceutical Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Bactine® Max Liquid Bandage

Active Ingredients (w/w)

Benzalkonium Chloride 0.13%

Lidocaine 4%

Purpose 

First aid antiseptic

External Analgesic

Uses

First aid to help prevent bacterial skin infection and for temporary relief of pain or discomfort in minor cuts, scrapes and burns.

Warnings

For external use only

Do not use

• If you are allergic to any of the ingredients
• in or near the eyes
• over large areas of the body
• longer than 1 week unless directed by a doctor
  

Ask a doctor before use if you have

• deep or puncture wounds
• deep cuts
• animal bites
• serious burns

When using this product

• do not apply over raw surfaces or blistered areas

Stop use and ask a doctor if

• condition worsens
• symptoms persist for more than 7 days, or clear up and occur again within a few days

Keep out of reach of children

• If swallowed, call a poison control center or get medical help right away.

Directions

• adults and children 2 years of age and older:
• shake well
• clean the affected area and apply a small amount up to 3 times daily and let dry 
• a second coating may be applied for extra protection 
• children under 2 years of age: ask doctor prior to use

Other information

Store at room temperature

Inactive ingredients

acrylates copolymer, alcohol denat, ammonium acrylates copolymer, disodium deceth-6 sulfosuccinate, disodium EDTA, laureth-30, propanediol, sodium dehydroacetate, water.

Questions?

1-844-241-5454 or Bactine.com

Distributed by:

*Germs commonly associated with skin infections.

Distributed by:

WellSpring Pharmaceutical Corporation
Sarasota, FL 34243

© 2022 WellSpring Pharmaceutical Corporation
MONEY BACK GUARANTEE

Bactine Max is FSA/HSA eligible.

PACKAGE LABEL. PRINCIPAL DISPLAY PANEL

New

Bactine Max

Liquid Bandage with Lidocaine

Max Pain Relief

Kills 99% of Germs 

Prevents Infection 

Relieves    Kills     Prevents 

NO STING 

SHAKE WELL

Back Panel

New

Bactine Max

Liquid Bandage with Lidocaine

SHAKE WELL

Bactine Max Liquid Bandageʼs unique formula provides maximum strength pain relief with LIDOCAINE, kills 99.9% of germs*, and prevents infection for hard-to-cover cuts and scrapes. This flexible bandage dries clear quickly and is breathable to maximize healing.

BACTINE MAX 
benzalkonium chloride and lidocaine hydrochloride liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 65197-830
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y)	BENZALKONIUM CHLORIDE	0.13 g  in 100 mL
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE HYDROCHLORIDE ANHYDROUS	4 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
EDETATE DISODIUM (UNII: 7FLD91C86K)
PROPANEDIOL (UNII: 5965N8W85T)
WATER (UNII: 059QF0KO0R)
ALCOHOL (UNII: 3K9958V90M)
BUTYL ACRYLATE/METHYL METHACRYLATE/METHACRYLIC ACID COPOLYMER (18000 MW) (UNII: JZ1374NL9E)
LAURETH-30 (UNII: W9D845551A)
SODIUM DEHYDROACETATE (UNII: 8W46YN971G)

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 65197-830-03	1 in 1 BOX	03/15/2022	03/15/2022
1		10 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part333A	03/15/2022	03/15/2022

Labeler - WellSpring Pharmaceutical Corporation (110999054)

Revised: 8/2021

Document Id: 62aa056b-292d-4d3c-b18f-7928075122bb

34390-5

Set id: a328e536-d1ba-42e6-a119-5d3fbafecf13

Version: 2

Effective Time: 20210819